Novogene Co., Ltd. (SHA:688315)
14.05
-0.39 (-2.70%)
Jun 10, 2025, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 5.69 billion as of June 10, 2025. Its market cap has decreased by -9.22% in one year.
Market Cap
5.69B
Enterprise Value
4.26B
Revenue
2.14B
Ranking
n/a
PE Ratio
28.90
Stock Price
14.10
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 5.69B, a decrease of -48.10%. That is a compound annual growth rate of -14.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 9, 2025 | 5.85B | 15.52% |
Dec 31, 2024 | 5.06B | -47.88% |
Dec 29, 2023 | 9.71B | -8.02% |
Dec 30, 2022 | 10.56B | -36.10% |
Dec 31, 2021 | 16.53B | 50.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 356.59B |
Shenzhen Mindray Bio-Medical Electronics | 281.18B |
WuXi AppTec | 186.17B |
Sichuan Biokin Pharmaceutical | 132.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.35B |
Aier Eye Hospital Group | 116.45B |
Shanghai United Imaging Healthcare | 110.01B |
Yunnan Baiyao Group Co.,Ltd | 100.99B |